Transmyocardial laser revascularization: a meta-analysis and systematic review of controlled trials

Davy Cheng1, Anno Diegeler, Keith Allen

  • 1From the *Department of Anesthesia and Perioperative Medicine, London Health Sciences Centre, The University of Western Ontario, London, Ontario, Canada; †Herz-Und Gefasse Klinik Bad Neustadt, University of Leipzig, Bad Neustadt, Germany; ‡The Heart Center of Indiana, Division of Cardiothoracic Surgery, Indianapolis, Indiana; §Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; ∥University of Kiel School of Medicine, Kiel, Germany; ¶Texas Heart Institute at St Luke's Episcopal Hospital, Houston, Texas; **Division of Cardiovascular Surgery, Department of Surgery, Shiga University of Medical Science, Otsu, Japan; ††Rikshopitalet-Radiumhospitalet, Oslo, Norway; ‡‡National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland; and §§High Impact Technology Evaluation Centre, London Health Sciences Centre, University Hospital, London, Ontario, Canada.

Abstract

No abstract available in PubMed .

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...